PMEF
BMY icon

Point72 Middle East FZE’s Bristol-Myers Squibb BMY Stock Holding History

Point72 Middle East FZE’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-102,444
Closed -$6.28M – 1478
2023
Q2 		$6.55M Buy
+102,444
New +$6.87M 0.18% 140

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Middle East FZE's BMY Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 102,444 shares — an estimated $6.28M sold.

Point72 Middle East FZE first reported a position in BMY in Q2 2023 and held it in 1 quarter. The position peaked at $6.55M in Q2 2023. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 102,444 Bristol-Myers Squibb shares in Q3 2023, an estimated $6.28M.
  • Point72 Middle East FZE first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Bristol-Myers Squibb position peaked at $6.55M in Q2 2023.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.